Does circulating erythropoietin reflect progression of IgA nephropathy?: Comparison with urinary N-acetyl-β-D-glucosaminidase

被引:18
|
作者
Machiguchi, T
Yoshida, H
Yonemoto, S
Minakata, T
Nomura, K
Muso, E
Tamura, T
Sasayama, S
机构
[1] Kitano Hosp, Inst Med Res, Div Nephrol, Kita Ku, Osaka 5300026, Japan
[2] Himeji Natl Hosp, Dept Internal Med, Himeji, Hyogo, Japan
[3] Kyoto Univ, Dept Cardiovasc Med, Kyoto 606, Japan
关键词
anaemia; erythropoietin; glomerulosclerosis; IgA nephropathy; N-acetyl-beta-D-glucosaminidase; tubulointerstitial damage;
D O I
10.1093/ndt/14.3.635
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Recent reports describe that erythropoietin (Epo) is produced by peritubular interstitial fibroblast-like cells in response to a hypoxic stimulus. We studied serum Epo levels as a possible marker of tubulointerstitial damage in the progression of IgA nephropathy (IgAN), in comparison with urinary (u-) levels of N-acetyl-beta-D-glucosaminidase (NAG), which is mainly derived from proximal tubular cells and is used as a marker of tubular damage. Methods. Thirty-eight patients with IgA nephropathy (IgAN) with relatively preserved renal function (serum creatinine: sCr, 0.5-2.2mg/dl) were examined. The severity of glomerulosclerosis and interstitial fibrosis of the renal biopsy tissue was expressed by semiquantitative grading scores. Clinical parameters including serum creatinine (sCr), blood pressures, and 24-h proteinuria levels were obtained at the renal biopsy. Epo was measured by a radioimmunoassay (RIA) of sera obtained in the morning and u-NAG was measured by colorimetric method of 24-h urine samples. Results. The mean Epo level of the patients ( 17.7 +/- 6.3 mU/ml) was not different from the control level (19.3 +/-3.7 mU/ml). There were no significant correlations between Epo levels and red blood cell (RBC) counts, haematocrit (Hct), or haemoglobin (Hb) levels. The mean u-NAG level of the patients (6.7 +/- 6.2 U/gCr) was significantly higher than the control level (1.9+/-0.5 U/gCr). There was an inverse quantitative correlation between Epo and u-NAG levels in the patients (P<0.02). The u-NAG levels showed quantitative positive correlations with sCr (P<0.001), u-proteins (P<0.001), systolic (SBP) (P<0.001), and diastolic blood pressures (DBP) (P<0.05). Conversely, Epo levels were inversely correlated with sCr, SEP and DBP (each P<0.05). The patients with higher u-proteins (> 2.0 g/day) showed significantly decreased Epo levels (P<0.05) than those with lower u-proteins (<2.0 g/day). The both scores of glomerulosclerosis and interstitial fibrosis were positively correlated with the u-NAG levels (each P<0.001), but were not correlated with the Epo levels. Conclusions, The significant correlation between u-NAG and serum Epo levels suggests that tubular damage and interstitial cell dysfunction are associated each other in the progression of IgAN. Serum Epo levels bearing inverse correlations with sCr, blood pressure levels and heavy proteinuria seem to reflect clinical severity of IgAN, whereas u-NAG can be more useful progression marker of IgAN bearing correlations with both clinical and histological findings.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 50 条
  • [1] Influence of hyperfiltration on the measurement of urinary N-acetyl-β-D-glucosaminidase
    Müller, D
    Sievers, E
    Eggert, P
    PEDIATRIC NEPHROLOGY, 1999, 13 (06) : 519 - 523
  • [2] Isoenzyme A and Urinary N-Acetyl-β-D-Glucosaminidase Activity in Normal Pregnancy
    Capodicasa, Enrico
    Angelini, Antonio
    Tassi, Carmelo
    RENAL FAILURE, 2011, 33 (06) : 650 - 653
  • [3] Correlation between Asymptomatic Leukocyturia and Urinary N-Acetyl-β-D-glucosaminidase in Women
    Sekimizu, Ken-ichi
    Suzuki, Tatsuya
    Igari, Yoshimasa
    Okazaki, Masaru
    Hashimoto, Masao
    Suzuki, Kazunari
    Ouchi, Motoshi
    Watanabe, Kentaro
    Nakano, Hiroshi
    Oba, Kenzo
    RENAL FAILURE, 2012, 34 (09) : 1079 - 1083
  • [4] Urinary N-acetyl-β-D-glucosaminidase in epileptic children treated with antiepileptic drugs
    Csáthy, L
    Oláh, AV
    Clemens, B
    György, I
    Varga, J
    ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (05) : 420 - 422
  • [5] Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis
    Erdener, D
    Aksu, K
    Biçer, I
    Doganavsargil, E
    Kutay, FZ
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2005, 19 (04) : 172 - 176
  • [6] Urinary β-D-glucuronidase and N-acetyl-β-D-glucosaminidase in cisplatin nephrotoxicity in rat
    Mehanovic-Nikolic, J
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2000, 19 (01): : 21 - 24
  • [7] Angiotensin-Converting Enzyme Gene Polymorphism and N-Acetyl-β-D-Glucosaminidase Excretion in Endemic Nephropathy
    Pecin, Ivan
    Cvoriscec, Dubravka
    Miletic-Medved, Marica
    Dika, Zivka
    Cvitkovic, Ante
    Vitale, Ksenija
    Leko, Ninoslav
    Novakovic, Dinko
    Sertic, Jadranka
    Kos, Jelena
    Jelakovic, Bojan
    NEPHRON CLINICAL PRACTICE, 2011, 119 (02): : C105 - C112
  • [8] Expression modes of urinary N-acetyl-β-D-glucosaminidase in patients with chronic renal insufficiency
    Tassi, C
    Mancuso, F
    Feligioni, L
    Marangi, M
    Capodicasa, E
    CLINICA CHIMICA ACTA, 2004, 346 (02) : 129 - 133
  • [9] N-acetyl-β-D-glucosaminidase activity in urine of dental personnel
    Tassi, C
    Mancuso, F
    Lomurno, G
    Lotito, M
    Feligioni, L
    De Bellis, F
    Eramo, S
    Capodicasa, E
    CLINICA CHIMICA ACTA, 2004, 344 (1-2) : 211 - 213
  • [10] The pyrostatins A and B do not inhibit N-acetyl-β-D-glucosaminidase
    Appel, Daniel
    Lentzen, Georg
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (05) : 1106 - 1108